Penumbra Inc (PEN) - Total Assets
Based on the latest financial reports, Penumbra Inc (PEN) holds total assets worth $1.74 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Penumbra Inc's book value for net asset value and shareholders' equity analysis.
Penumbra Inc - Total Assets Trend (2013–2024)
This chart illustrates how Penumbra Inc's total assets have evolved over time, based on quarterly financial data.
Penumbra Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Penumbra Inc's total assets of $1.74 Billion consist of 62.0% current assets and 38.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $324.40 Million | 21.2% |
| Accounts Receivable | $167.67 Million | 10.9% |
| Inventory | $406.74 Million | 26.5% |
| Property, Plant & Equipment | $268.45 Million | 17.5% |
| Intangible Assets | $6.51 Million | 0.4% |
| Goodwill | $165.83 Million | 10.8% |
Asset Composition Trend (2013–2024)
This chart illustrates how Penumbra Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PEN market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Penumbra Inc's current assets represent 62.0% of total assets in 2024, a decrease from 87.5% in 2013.
- Cash Position: Cash and equivalents constituted 21.2% of total assets in 2024, up from 5.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 26.5% of total assets.
Penumbra Inc Competitors by Total Assets
Key competitors of Penumbra Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Penumbra Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.73 | 5.82 | 5.83 |
| Quick Ratio | 4.18 | 3.25 | 3.76 |
| Cash Ratio | 1.89 | 1.83 | 0.00 |
| Working Capital | $971.92 Million | $738.57 Million | $511.77 Million |
Penumbra Inc - Advanced Valuation Insights
This section examines the relationship between Penumbra Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.64 |
| Latest Market Cap to Assets Ratio | 8.32 |
| Asset Growth Rate (YoY) | -1.5% |
| Total Assets | $1.53 Billion |
| Market Capitalization | $12.76 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Penumbra Inc's assets at a significant premium (8.32x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Penumbra Inc's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Penumbra Inc (2013–2024)
The table below shows the annual total assets of Penumbra Inc from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.53 Billion | -1.49% |
| 2023-12-31 | $1.56 Billion | +13.53% |
| 2022-12-31 | $1.37 Billion | +10.18% |
| 2021-12-31 | $1.24 Billion | +51.19% |
| 2020-12-31 | $822.98 Million | +23.59% |
| 2019-12-31 | $665.90 Million | +29.30% |
| 2018-12-31 | $515.01 Million | +8.04% |
| 2017-12-31 | $476.67 Million | +54.63% |
| 2016-12-31 | $308.25 Million | +16.83% |
| 2015-12-31 | $263.85 Million | +117.37% |
| 2014-12-31 | $121.38 Million | +70.61% |
| 2013-12-31 | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also… Read more